Name
Session V: Chronic Myeloid Leukemia
Date & Time
Thursday, September 10, 2026, 10:25 AM - 11:47 AM
Description
Session V: Chronic Myeloid Leukemia
Session Chairs: Michael Deininger, MD, PhD and Jorge E. Cortés, MD
STAMP: Advantages and Pitfalls | Andreas Hochhaus, MD | Jena University Hospital, Jena, Germany
Good Response but Not DMR: What to Do | Ehab L. Atallah, MD | Medical College of Wisconsin, Milwaukee, Wisconsin, USA
AGA in CML: Potential Role and Therapeutic Strategies | Vivian Oehler, MD | Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Is There Still a Role for Allogeneic Transplant in CML? | Hugues de Lavallade, MD, PhD | Guy's & St Thomas' NHS Foundation Trust, London, United Kingdom
Oral Abstract | TBD | Speaker | Affiliation
Speakers
Ehab Atallah, Medical College of Wisconsin
Jorge Cortés, University of Alabama
Hugues De Lavallade, Guy's & St Thomas' NHS Foundation Trust
Michael Deininger, University of Michigan
Andreas Hochhaus, Jena University Hospital
Vivian Oehler, Fred Hutchinson Cancer Research Center
Jorge Cortés, University of Alabama
Hugues De Lavallade, Guy's & St Thomas' NHS Foundation Trust
Michael Deininger, University of Michigan
Andreas Hochhaus, Jena University Hospital
Vivian Oehler, Fred Hutchinson Cancer Research Center
Location Name
General Assembly, Level 3 GRB Convention Center